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ABSTRACT Unbinding of a spin-labeled dinitrophenyl (DNP) hapten from the monoclonal antibody AN02 Fab fragment has
been studied by force probe molecular dynamics (FPMD) simulations. In our nanosecond simulations, unbinding was
enforced by pulling the hapten molecule out of the binding pocket. Detailed inspection of the FPMD trajectories revealed a
large heterogeneity of enforced unbinding pathways and a correspondingly large flexibility of the binding pocket region, which
exhibited induced fit motions. Principal component analyses were used to estimate the resulting entropic contribution of 6
kcal/mol to the AN02/DNP-hapten bond. This large contribution may explain the surprisingly large effect on binding kinetics
found for mutation sites that are not directly involved in binding. We propose that such “entropic control” optimizes the
binding kinetics of antibodies. Additional FPMD simulations of two point mutants in the light chain, Y33F and I96K, provided
further support for a large flexibility of the binding pocket. Unbinding forces were found to be unchanged for these two
mutants. Structural analysis of the FPMD simulations suggests that, in contrast to free energies of unbinding, the effect of
mutations on unbinding forces is generally nonadditive.
INTRODUCTION
Molecular recognition is essential for many biochemical
processes and may be realized by highly specific binding of
ligands to their receptors. In the immune system, antibodies
play a crucial role by recognizing and specifically binding
their antigens. Calorimetric, spectroscopic, kinetic, and
structural data on antibody/antigen systems have been ac-
cumulated (Padlan, 1994). Antibodies are widely used in
biotechnology, pharmaceutics (Dickman, 1998), and as cat-
alysts (Kristensen et al., 1998). For a better understanding of
the antigen-binding mechanism insight into its molecular
dynamics at the atomic level is essential.
Recent advances in single molecule atomic force micros-
copy (AFM) and other force probe techniques allow one to
study mechanical properties of individual molecules such as
the binding forces of protein-ligand complexes (Lee et al.,
1994b; Florin et al., 1994; Moy et al., 1994), the enforced
unfolding of proteins (Rief et al., 1997a; Kellermayer et al.,
1997; Tskhovrebova et al., 1997), or the stiffness of other
polymers, such as DNA (Lee et al., 1994a) or polysaccha-
rides (Rief et al., 1997b). Also, and motivating the present
work, single-molecule AFM studies on a number of anti-
body/antigen complexes have been carried out (Hinterdorfer
et al., 1996; Dammer et al., 1996; Allen et al., 1997; Ros et
al., 1998), and more are under way.
Computer simulations of such AFM experiments (Grub-
mu¨ller et al., 1996; Konrad and Bolonick, 1996; Rief et al.,
1997b; Izrailev et al., 1997; Marrink et al., 1998; Lu et al.,
1998; Heymann and Grubmu¨ller, 1999a–c) by means of
“force probe” molecular dynamics (FPMD) simulations can
provide models that explain the measured forces in terms of
molecular structures, unbinding reaction pathways, and in-
teratomic interactions. They thereby complement single
molecular AFM experiments with microscopic interpreta-
tions. Such simulations can and have to be validated by
computing unbinding forces from the simulations and com-
paring these with experiments. Such a comparison is com-
plicated by the fact that AFM experiments are typically
carried out on a millisecond time scale or slower, whereas
MD simulations are currently limited to nanoseconds. Be-
cause the unbinding force generally depends on how fast the
unbinding is enforced, care has to be taken when relating
simulations to experiments (Grubmu¨ller et al., 1996; Izrai-
lev et al., 1997; Marrink et al., 1998).
In a prior publication we reported the computation of
unbinding forces of an antibody/hapten complex from nano-
second FPMD simulations (Heymann and Grubmu¨ller,
1999a). In particular, we studied the enforced unbinding of
a spin-labeled dinitrophenyl (DNP-SL) hapten from the
AN02 antibody. The AN02 antibody is one of 12 monoclo-
nal anti-dinitrophenyl spin-label antibodies that have been
characterized in terms of their cDNA sequences and binding
constants (Leahy et al., 1988). The AN02 antibody is par-
ticularly well-characterized by NMR measurements (Theri-
ault et al., 1991, 1993; Martinez-Yamout and McConnell,
1994) and picosecond MD simulations (Theriault et al.,
1993).
To rescale the unbinding forces computed from our
AN02 FPMD simulations from the nanosecond simulation
time scale to the experimental millisecond time scale (and
longer), a scaling model has been developed and applied
(Heymann and Grubmu¨ller, 1999a). This model considers
both friction and activated processes and makes use of the
measured spontaneous dissociation rate for the AN02/DNP-
hapten complex and the unbinding length that was estimated
Received for publication 5 January 2001 and in final form 2 May 2001.
Address reprint requests to Helmut Grubmu¨ller, Theoretical Molecular
Biophysics Group, Max Planck Institute for Biophysical Chemistry, Am
Fassberg 11, 37077 Go¨ttingen, Germany. Tel.: 49-551-201-1763; Fax:
49-551-201-1089; E-mail: hgrubmu@gwdg.de.
© 2001 by the Biophysical Society
0006-3495/01/09/1295/19 $2.00
1295Biophysical Journal Volume 81 September 2001 1295–1313
from the simulations. From this approach, we predicted an
unbinding force of 60  30 pN for the millisecond time
scale. We expect experimental AFM data on this system to
be available soon.
In this paper we focus on the microscopic interpretation
of the unbinding forces of the AN02/DNP-hapten complex
in terms of physical interactions and unbinding pathways.
To that end, we consider both the interactions between the
ligand and individual AN02 binding pocket residues and
more structural aspects of the unbinding pathways. In par-
ticular, we focus on a possible structural heterogeneity of
the unbinding pathway, which is assumed to cause signifi-
cant scatter of unbinding forces. Such scatter has already
been observed in a number of systems (Florin et al., 1994;
Moy et al., 1994; Grubmu¨ller et al., 1996), but was gener-
ally attributed to experimental or statistical error rather than
structural heterogeneity. For the bound AN02 complex,
structural heterogeneity has been observed by NMR (The-
riault et al., 1991; Martinez-Yamout and McConnell, 1994).
Particularly, the light chain Tyr-31 was suggested to be
rather flexible in these studies, and to contribute to induced
fit motions upon binding (McConnell and Martinez-
Yamout, 1996).
To investigate the microscopic nature of such structural
heterogeneity and to assess its relevance for a proper de-
scription of the kinetics of binding and unbinding, we shall
attempt to quantify the entropic contribution to the free
energy barrier of enforced unbinding that results from that
heterogeneity. To this end, principal component analyses of
the unbinding trajectories will be used.
The importance of individual residues with respect to
ligand binding is traditionally judged from site-directed
mutagenesis of putative residues by measuring the change
in free energy with respect to the wild type. Typically, that
change can also be estimated from the x-ray structure by
counting hydrogen bonds, salt bridges, or van der Waals
contacts between ligand and binding pocket. Aiming at
extending this procedure toward forces, we identified criti-
cal hydrogen bonds that are expected to significantly reduce
the AN02/DNP-hapten binding free energy.
To answer the question of how those crucial residues also
affect unbinding forces, we modeled two mutants of AN02
and carried out another series of FPMD simulations for each
of the two mutants. In the first the mutant, the light chain
Tyr-33 that interacts with the hapten molecule via a strong
hydrogen bond was replaced by phenylalanine, which can
not form such a hydrogen bond. The binding constant of that
mutant is smaller than that of the wild type by a factor of 10
(Martinez-Yamout and McConnell, 1994). Accordingly, we
also expected to find lower unbinding forces. In the other
mutant, which has not been studied previously, the interac-
tion between hapten and the binding pocket was increased
by replacing Ile-96 by lysine. The lysine is expected to form
an additional strong hydrogen bond to the hapten molecule,
which should give rise to an increased unbinding force for
this mutant.
COMPUTATIONAL METHODS
Simulation systems and FPMD
simulation methods
As a start, the x-ray structure of the AN02 Fab fragment complexed with the
DNP-SL ligand (Bru¨nger et al., 1991) was taken from the Brookhaven
Protein Data Bank (Bernstein et al., 1977), entry 1baf. All molecular
dynamics simulations were performed with the parallel MD program EGO
(Eichinger et al., 2000) (Eichinger, M., H. Grubmu¨ller, and H. Heller.
1995. User Manual for EGO_VIII, Release 2.0. Electronic access: ww-
w.mpibpc.gwdg.de/abteilungen/071/ego.html) and the CHARMM force
field (Brooks et al., 1983). EGO allows efficient computation of Coulomb
forces using the “fast multiple time step structure adapted multipole
method” (Eichinger et al., 1997; Grubmu¨ller and Tavan, 1998), so that no
artificial truncation of these forces had to be applied (Brooks et al., 1983).
For the DNP-hapten, partial charges were calculated with UNICHEM
(Cray Research Inc. 1997. UniChem 3.0. 655 Lone Oak Drive, Eagan, MN
55151.) (see Fig. 1) using MNDO94, the AM1 Hamiltonian, ESP-fitting,
and a dielectric constant of one. All force constants were taken from the
CHARMM force field (Brooks et al., 1983). All simulations were carried
out with an integration step size of 1015 s. The length of chemical bonds
involving hydrogen atoms was fixed (McCammon et al., 1977), and non-
polar hydrogen atoms were treated through compound atoms (Brooks et al.,
1983). No explicit term for the hydrogen bond energy was included within
the force field.
FIGURE 1 Structure of the spin-labeled dinitrophenyl hapten; shown are
names and partial charges as computed with UNICHEM and used in the
simulations.
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A model for the solvated protein-ligand complex was built by surround-
ing the x-ray structure with a droplet containing 13,461 TIP3 (Jorgensen et
al., 1983) water molecules, 34 Na ions, and 41 Cl ions at physiological
concentration using the program SOLVATE (Grubmu¨ller, H. 1996. Sol-
vate: a program to create atomic solvent models. Electronic access: ww-
w.mpibpc.gwdg.de/abteilungen/071/hgrub/solvate/docu.html) [see Fig. 2
A]. The ions were placed according to a Debye-Hu¨ckel distribution gov-
erned by the protein and hapten charges. The excess of seven Cl ions
served to compensate the net positive charge of the complex. To keep the
number of solvent molecules in the system as small as possible, a non-
spherical solvent volume was chosen. The solvent surface was defined such
that the minimum distance between the protein surface and the solvent
surface was 20 Å near the binding pocket region and 12 Å elsewhere. The
obtained simulation system comprised a total of 44,571 atoms.
To counterbalance surface tension and to prevent evaporation of water
molecules, all surface water molecules were subjected to a “deformable
boundary” (Brooks and Karplus, 1983), which has been adapted to water
solvent and approximated by a quartic polynomial (Kossmann, 1997).
Additionally, all water molecules at the droplet surface were coupled to a
heat bath of 300 K through stochastic forces obeying the fluctuation-
dissipation theorem (Reif, 1965). A coupling constant of   10 ps1 was
used. All other atoms were weakly coupled to a heat bath (  1 ps1) via
velocity rescaling (Berendsen et al., 1984).
After energy-minimizing the whole system by 1000 steepest descent
steps, the system was equilibrated for 1500 ps at 300 K. During equilibra-
tion, the stability of the complex was monitored via its root mean square
(rms) deviation from the x-ray structure (“forward deviation”) and, as
suggested by Stella and Melchionna (1998), also from the structure after
equilibration (“backward deviation”). Following the suggestion of one of
the referees, structural motions observed during equilibration were com-
pared to structural flexibility obtained from a comparison of six related
x-ray structures with each other using the program DynDom (Hayward and
Berendsen, 1998).
For the rms computations four sets of heavy atoms were considered,
namely those 1) of the complete protein-ligand complex, 2) of the variable,
and 3) of the constant domain regions, and 4) of the binding pocket,
respectively. Here, the binding pocket (referred to as “B” below) was
defined as those residues that interact with the hapten molecule during the
unbinding process, together with those parts of the hypervariable loops that
are located close to the hapten molecule. These comprised residues 30–
35(L), 47–52(L), and 86–99(L), as well as residues 30–36(H), 48–55(H),
and 97–105(H), respectively. Here, and also in the following, (L) and (H)
refer to the light and heavy chain.
The subsequent FPMD simulations were carried out as sketched in Fig.
2 B: in close resemblance to the pulling forces exerted in the single-
molecule AFM experiment by the cantilever, the spin-labeled oxygen atom
O2 of the hapten was subjected to a “spring potential” Vspring,
VspringzO2 : 12 kcant	zO2t zcantt

2, (1)
acting in a pulling direction on the z-coordinate zO2 of atom O2. Here,
zcant(t) is the cantilever position. A spring constant of kcant 280 pN/Å was
used throughout all simulations.
In the figure, Vspring is symbolized by a spring. Note that Vspring as
defined above does not restrain sideward motions of the O2 atom, i.e.,
perpendicular to the z-direction, because such motions are also essentially
unconstrained in the experiments. At the beginning of each FPMD simu-
lation, the minimum position, zcant(0), of Vspring was placed at the position
of atom O2, zO2(0). In the course of each simulation, Vspring was moved in
the pulling direction with a constant pulling velocity vcant (arrow), i.e.,
zcant(t)  zcant(0)  vcantt.
To avoid larger sideward drift of the hapten, atom O2 was additionally
subjected to a weak harmonic potential (spring constant: 14 pN/Å) per-
pendicular to the pulling direction. Finally, the center of mass of the protein
(with hapten excluded) was kept in place by a relatively stiff harmonic
potential (force constant: 2800 pN/Å). This setup allowed the protein to
adapt to the enforced hapten unbinding, e.g., by rotations or intramolecular
conformational motions like induced fit motions, also in close resemblance
to typical AFM experiments.
During enforced unbinding, the pulling force Fpull(t)  kcant[zcant(t) 
zO2(t)] acting on the oxygen atom was calculated and recorded every 100
fs. Thus, a “force profile” for each FPMD simulation was obtained as a
function of cantilever position zcant(t). An unbinding force was defined as
the maximum of the respective force profile, and the position of the O2
atom at that maximum was recorded to obtain an “unbinding length”
(Heymann and Grubmu¨ller, 1999a). The relatively stiff spring constant of
kcant  280 pN/Å for the spring potential was chosen to provide high
spatial resolution of the force profile of kBT/kcant  0.5 Å while allowing
thermal fluctuations of about the same size (Heymann and Grubmu¨ller,
2000). High-frequency fluctuations of atom O2, which were artificially
caused by the harmonic spring potential, were filtered by properly smooth-
ing the force profiles (Grubmu¨ller et al., 1996).
To characterize the velocity dependence of the unbinding forces and to
allow proper statistical analysis of the unbinding pathways, a total of 58
FIGURE 2 (A) Model of the solvated AN02 (red)/DNP hapten (green)
complex used in the molecular dynamics simulations described in the text.
The complex has been surrounded by water molecules (blue); ions (yellow)
were placed according to a Debye-Hu¨ckel distribution governed by the
protein and hapten charges. (B) General setup of the force probe molecular
dynamics (FPMD) simulations. Shown is the AN02 Fab fragment (ribbon
plot) and the hapten molecule (ball-and-stick model). The oxygen atom O2
was subjected to a harmonic potential (spring), which was moved in the
pulling direction (arrow) with constant pulling velocity vcant.
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FPMD simulations were carried out. For computation of the unbinding
force as a function of the pulling velocity, 29 simulations were used. For
these simulations, pulling velocities in the range between 0.1 and 50 m/s
were chosen requiring simulation lengths between 30 and 7000 ps to
complete the unbinding process in each case (Heymann and Grubmu¨ller,
1999a). To study the structural heterogeneity of the enforced unbinding
pathways, 20 FPMD simulations of 300 ps length each were carried out
with identical pulling velocity, vcant  5 m/s. These simulations differed in
their initial conformations, which were picked randomly from the last 820
ps of the 1500-ps equilibration trajectory.
Based on the equilibrated wild-type structure (taken from the equilibra-
tion phase at 1300 ps), two mutants of the AN02/DNP-hapten complex
were modeled. Here our goal was to identify two mutation sites with
opposite effects: the first one should decrease, the second one should
increase the unbinding force. To that end, we first selected a hydrogen
bond between Tyr-33(L) and the DNP molecule which, as judged from our
prior FPMD simulations, strongly contributed to the unbinding force. That
bond was then removed by a Y33F(L) mutation. The second mutant,
I96K(L), was obtained by identifying the oxygen atom O25 of the DNP
ring as a putative hydrogen bond acceptor, and by changing a suitably
located isoleucine residue to lysine as a hydrogen bond donor.
To generate a model for the Y33F(L) mutant, the Tyr-33(L) side-chain
hydroxyl group was removed and the force field was changed accordingly
using the XPLOR (Bru¨nger, 1988) phenylalanine force field parameters.
The system was subsequently equilibrated for 50 ps.
The I96K(L) mutation required particular attention because here a
charged NH3 group had to be inserted. This was achieved using the
molecular editor of the software package Quanta (Molecular Simulations
Inc., 1997). Care was taken that no overlap with neighbored amino acids
occurred. To compensate the positive net charge of lysine, a nearby sodium
ion was removed. The resulting structure was equilibrated for 100 ps.
Starting from the respective equilibrated structures, each of the mutants
was subjected to 22 FPMD simulations to allow accurate comparison of
unbinding forces between the mutants and the wild type. Pulling velocities
from 50 m/s to 2 m/s were used.
Analysis of FPMD unbinding simulations
For each of the FPMD simulations, changes of the interaction network
between the hapten molecule and the AN02 Fab fragment during unbinding
were recorded and characterized by computing selected observables as a
function of the cantilever position zcant. These were the total electrostatic
(Coulomb) and van der Waals (Lennard Jones) interactions 1) between
hapten and AN02 and 2) between hapten and selected individual residues
of the AN02 binding pocket, and formation and rupture of 3) hydrogen
bonds and 4) water bridges between hapten and the relevant AN02 binding
pocket residues. As relevant binding pocket residues we selected those
residues which, in the course of the FPMD simulations, show significant
electrostatic or van der Waals interactions with the hapten. Those were
Trp-90(L), Tyr-33(L), Tyr-31(L), Asp-49(L), Ile-96(L), Gln-88(L), Trp-
100(H), Tyr-51(H), Pro-101(H), and Tyr-54(H), and will be referred to as
“R” below.
From the FPMD trajectories the electrostatic and van der Waals ener-
gies, respectively, among all atoms of the DNP molecule and all atoms of
the protein and among all atoms of the DNP molecule and all atoms of the
selected binding pocket residues were computed using XPLOR (Bru¨nger,
1988). A cutoff of 10 Å was used for these energy computations. Energies
were computed once per picosecond by averaging the values of 10 snap-
shots taken every 100 fs for each picosecond. To assess the integrity of the
binding pocket during equilibration, this analysis has also been carried out
on the 1500-ps equilibration trajectory for comparison.
Strength, formation, and rupture of hydrogen bonds between hapten and
the binding pocket residues in the course of the unbinding process was
monitored using a combined geometric and energetic criterion for the
identification and quantification of hydrogen bonds (Kitao et al., 1993).
Accordingly, a hydrogen bond was identified if the involved heavy atoms
were closer to each other than 4 Å and if the sum of van der Waals and
electrostatic energy was negative and its absolute value 1 kcal/mol. This
sum was used to measure the strength of the identified hydrogen bonds.
Water bridges between the hapten molecule and binding pocket residues
were identified by requiring a water molecule to simultaneously form two
hydrogen bonds, one to the hapten molecule and one to a binding pocket
residue.
To structurally characterize the unbinding pathway of the hapten mol-
ecule and induced-fit motions of the whole binding pocket “B,” FPMD
trajectories were analyzed in detail. Particular attention was paid to ligand
motions relative to the light chain residues and to the heavy chain residues
of the binding pocket (cf. Fig. 13). Only trajectories from FPMD simula-
tions with pulling velocities (vcant  2 m/s) were considered for this
purpose because those frictional effects have been shown to be negligible.
These simulations are thus assumed to best describe enforced unbinding as
seen in the AFM experiments. Figures were prepared with Molscript
(Kraulis, 1991) and MOLMOL (Koradi et al., 1996).
Principal component analysis (PCA) (Mardia et al., 1979) was used to
estimate the size of the region in configurational space (of both ligand and
binding pocket residues “B”) covered by the ensemble of unbinding
pathways obtained in our FPMD simulations. Generalizing the entropy
estimate of protein structure ensembles suggested by Karplus and Kushick
(1981) and improved by Schlitter (1993) to ensembles of trajectories, the
PCA results were used to estimate the entropic contribution to the free
energy along the unbinding pathway and, in particular, to the free energy
barrier that governs the AN02/DNP-hapten binding kinetics. This proce-
dure is described in the subsequent Theory section.
A total of 20 FPMD simulations has been used for the entropy estimate,
each of 300 ps length. From each trajectory, 3000 coordinate sets (one per
100 fs) were taken for the PCA. These sets included the whole binding
pocket “B” and the hapten molecule, comprising a total of 475 atoms.
As illustrated in Fig. 3 and explained in the Theory section, the coor-
dinate sets were split into n  131 overlapping subsets according to the
reaction coordinate zcant(t) using intervals Ii(i  1, . . . , n) of 2 Å width
each. The intervals were shifted along zcant(t) in 0.1 Å steps in the range
between 0 Å (bound state) and 15 Å (unbound state). The obtained 131
coordinate subsets of 400 coordinate sets each were then evaluated using
Eq. 11.
The relative contribution of the individual degrees of freedom to the
configurational entropy change was calculated from the partial entropy
FIGURE 3 Sketch of the unbinding pathways of the hapten molecule out
of the AN02 binding pocket. The volume covered by all unbinding path-
ways in a given interval Ii of cantilever positions zcant is used to estimate
the entropy of the complex.
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differences Sm(zcant) with m  50, 55, 60, . . . , 100. Larger values for m
were not considered because at the chosen spatial resolution of vcantt 
2 Å only 400 coordinate sets were available for each zcant value.
THEORY: ENTROPY ESTIMATE FOR
REACTION PATHWAYS
We assume a given ensemble {x(i)(t)}i1. . .n of n MD tra-
jectories along a reaction pathway with a Boltzmann en-
semble {x(i)(0)}i1. . .n of initial conditions (see Fig. 3).
Here, x(i)(t)  3N is the configuration vector of trajectory
i at time t, where N is the number of atoms considered.
Using this ensemble of trajectories, and generalizing the
usual expression for the entropy in the canonical ensemble
(Reif, 1965), we want to estimate how the entropy of this
system changes in time as the system is forced to move
along a reaction pathway,
StkBd3Nxx, tln x, t, (2)
where (x, t) is the time-dependent configuration space
density that generates the trajectory ensemble {x(i)(t)}. In
the above equation, the integral is taken over the full
configurational space. (Because velocity-dependent
forces are absent, the contribution of the momenta to the
free energy is a constant and is thus irrelevant for the
present purpose.)
Note that for the case at hand the ensemble moves
along the unbinding reaction pathway with constant ve-
locity, zcant  tvcant, hence S(t) will be interpreted as the
(configurational) entropy contribution to the free energy
landscape along the unbinding reaction pathway as de-
fined by the reaction coordinate zcant. Note also that, in
defining S(t) via Eq. 2, we assume that all degrees of
freedom perpendicular to the reaction pathway are in
equilibrium at all times; the same assumption is made in
Kramers’ transition state theory (Eyring, 1935; Kramers,
1940).
For the stationary case, entropy estimates are available.
As implicitly assumed by Karplus and Kushick (1981), (x)
can be approximated by a multivariate Gaussian function
˜(x) centered at x0 (Grubmu¨ller, 1995),
x  ˜x : Z˜1exp 12 x x0TAx x0, (3)
with partition function
Z˜ : d3Nx exp 12 x x0TAx x0. (4)
Here, A  3N3N is a symmetric, positive semidefinite
matrix which defines the shape of the Gaussian. It is derived
from the covariance matrix of the coordinate sets (Gardiner,
1985), C,
A1 C : 	x(i) x0
	x(i) x0
Ti with x0 : x(i)i,
(5)
and can therefore be computed from an MD trajectory.
Within this approximation the (classical) entropy S 
kB  d3Nx(x) ln (x) can be computed (up to an additive
constant) from the determinant of the covariance matrix
(Karplus and Kushick, 1981), S  1⁄2kB ln C, or, equiva-
lently, from the product of the (nonzero) eigenvalues of the
covariance matrix.
That estimate, however, suffers from instabilities caused
by small eigenvalues that are unphysical in that these insta-
bilities would vanish in a quantum-mechanical treatment of
the above approximation. A correction has therefore been
proposed (Schlitter, 1993),
S
1
2 kBlnCM1
2
kBTe2
 , (6)
which provides a better entropy estimate, and also cures the
instabilities. Here, M is the diagonal mass matrix that con-
tains the atomic masses,  is Planck’s constant, and e 
2.718 . . . is the Euler number.
We shall use Eq. 6 to estimate the time-dependent en-
tropy S(t) defined in Eq. 2. However, a straightforward
generalization of Eq. 6 is hampered by the fact that, because
of the small number of trajectories usually available (n 20
in our case) for each instance in time tj, the covariance
matrix computed from {x(i)(tj)} would be inaccurate due to
statistical error. Furthermore, the covariance matrix would
have too few (n  1) nonvanishing eigenvalues, which
means that only n  1 out of the total number of 3N  6
internal degrees of freedom would be considered for the
entropy estimate—most likely too few.
We therefore rewrite Eq. 2 as
St  dtd3Nxx, tlnx, tt t, (7)
where (t) is the Dirac delta function. Assuming that the
inner integral in Eq. 7 is a smooth function on a short
time scale t, (t) can be replaced by a (finite) square
function, and an approximation for the entropy is ob-
tained
St   dtd3Nxx, tln x, t
	
1


	t t t
. (8)
Here (t) is the step function, which is 0 for t  0 and 1
otherwise. With the above condition of smoothness, S(t) can
Antibody/Antigen Unbinding Simulations 1299
Biophysical Journal 81(3) 1295–1313
further be approximated by the time-averaged value of the
inner integral,
St   d3Nxx, tln x, ttt...tt,
  d3Nxx, ttt...ttlnx, ttt...tt,
(9)
for which Eq. 6 is applicable with the understanding that
now the subensemble of structures {x(i)(tj)}ttjtt is to
be used for the computation of the covariance matrix C,
which thus becomes a function of t. For sufficiently large
t, that ensemble is large enough such that a sufficient
number of degrees of freedom enters into the entropy
estimate.
Using the subensemble of the first interval as the (arbi-
trarily chosen) zero point, the entropy change along the
unbinding reaction pathway is then readily estimated,
Szcant Stvcant

1
2 kBln
CtM12/kBTe2
C0M12/kBTe2
. (10)
The resulting entropy difference S(zcant) serves to quan-
tify the entropic contribution to the free energy caused by
the structural heterogeneity of the unbinding pathways. Fur-
thermore, by replacing the two determinants in Eq. 10 by
products of the respective eigenvalues l(t) (which we as-
sume for each t to be ordered by decreasing size),
Szcant
1
2 kB 
l1
3N
ln
lt
l0
, (11)
the relative contribution of each (collective) degree of free-
dom l to the entropy change S(zcant) can readily be seen.
Because, typically, this relative contribution is large for
those degrees of freedom with large eigenvalues (Garcı´a,
1992; Kitao et al., 1991; Amadei et al., 1993; Schulze et al.,
2000) and vanishes for those with small eigenvalues, partial
entropies Sm(zcant) of the first m terms in Eq. 11 can be
used as a check for proper convergence.
RESULTS AND DISCUSSION
Equilibration
Fig. 4 shows the rms deviation for selected regions of the
AN02 antibody during equilibration. From the traces for the
constant region (top left), the variable region (bottom left),
and the binding pocket “B” (top right), a significant increase
from the x-ray structure (t 0) during the first 100 ps of the
equilibration is seen. After this short relaxation period, the
region of interest, namely the binding pocket region, shows
no further drift from the x-ray structure and stabilizes at the
relatively small rms value of 1.4 Å. Small drifts are seen,
however, for the constant and variable regions, respectively.
FIGURE 4 Root-mean-square (rms) deviation of selected regions of the AN02 antibody with respect to the x-ray structure during equilibration.
Considered are the constant region (top left), the variable region (bottom left), and the binding pocket region (top right), respectively. Root-mean-square
deviations per residue are shown in the bottom right panel where rms deviations of 3 Å are highlighted in black.
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Although the stability of the binding pocket region seems
to be established, the slow rms drifts of the constant and the
variable regions deserved further study. To that end, Fig. 4
(bottom right) plots the rms deviation per residue; rms
deviations of 3 Å are highlighted in black. These regions of
high mobility are also highlighted in black in Fig. 5, where
the AN02 x-ray structure (left) and the structure after equil-
ibration (right) are shown as ribbon plots. As can be seen,
all high-mobility regions are loops at the protein surface. In
contrast, the  scaffold, and in particular the binding pocket,
appear nearly unchanged.
An even larger rms drift shows up in Fig. 6, where the
rms deviation of the complete AN02/hapten complex during
equilibration is shown (heavy line). Here an rms value of 3.1
Å is reached at the end of the equilibration phase, and no
clear evidence for convergence is seen. That deviation is
significantly larger than that of the individual chains, as
seen in Fig. 4 (left), which suggests that this increased
deviation is mainly due to very slow motions of the constant
region relative to the variable region.
In this case, the relatively large drift of 3.1 Å seen for the
whole Fab fragment would likely result from (equilibrium)
sampling motions of the domains rather than from (non-
equilibrium) relaxation motions. To distinguish between
these two cases, it has been suggested (Stella and Mel-
chionna, 1998) to additionally consider the backward devi-
ation (thin line in Fig. 6), which measures the deviation
from the equilibrated (final) structure.
In contrast to the forward rms deviation, the backward
deviation stays small (below 1.7 Å) between 550 and 1300
ps, and exhibits only slight drift during that period. Note
also that the abrupt drop to zero between 1300 and 1500 ps
must be attributed to equilibrium fluctuations, because oth-
erwise a corresponding rms change would show up during
that period in the forward deviation as well, which is not the
case. Therefore, following the argumentation of Stella and
Melchionna (1998), we assume that the main relaxation
motions take place during the first 550 ps of the equilibra-
tion phase and that the period after 550 ps, in particular the
obvious rms drift, is characterized by slow equilibrium
sampling motions.
Closer inspection of snapshots during equilibration (not
shown) supports this view and reveals a hinge bending
motion of the variable region domain of the Fab fragment
with respect to the constant region domain around the two
loops connecting these two regions. The variable region,
which contains the binding pocket, stayed unchanged dur-
ing equilibration.
This observation is in full agreement with the conforma-
tional flexibility of the Fab fragment as obtained from a
selection of AN02 homologs (Brookhaven Protein Data
Bank entries 1hin:L, 1ifh:L, 1him:J, 1him:H, 1hil:C, and
1hil:A), which have been identified as “structural neigh-
bors” with SCOP (Murzin et al., 1995). From these struc-
tures, and in a similar manner as suggested previously (Van
Aalten et al., 1997), a hinge-bending flexibility between the
constant and variable domain region was identified with
angles between 7 and 16° and a hinge axis similar to the one
observed in the MD simulation (data not shown). Averaged
over all 15 pairs of the above six structures, the heavy atom
mean rms deviation is 1.33 Å for the whole Fab fragment
and 0.98 Å and 1.08 Å for the variable and constant do-
mains, respectively, which also documents the significant
contribution of the interdomain flexibility to the overall rms
deviations.
The interaction network that stabilizes the hapten mole-
cule within the binding pocket has been characterized from
the x-ray structure and other studies (Bru¨nger et al., 1991;
Anglister et al., 1987; Leahy et al., 1988; Theriault et al.,
1991, 1993; Martinez-Yamout and McConnell, 1994).
These interactions, shown in Fig. 7, are unchanged after the
equilibration phase. The DNP ring of the hapten molecule
(gray) is buried in a tryptophane sandwich formed by Trp-
FIGURE 5 Comparison of the AN02/DNP-hapten x-ray structure (left)
with a representative snapshot after equilibration (right). Regions with an
rms deviation 3 Å are shown in black (cf. Fig. 4, bottom right).
FIGURE 6 Root-mean-square (rms) deviation of the AN02/DNP-hapten
complex from the x-ray structure (“forward deviation,” heavy line) and
from the final, equilibrated structure (“backward deviation,” thin line).
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90(L) and Trp-100(H), and stabilized by contacts between
the aromatic rings. Several hydrogen bonds further stabilize
the complex; the strongest are shown in the figure (dashed
lines). Here, the hydrogen bond between Tyr-33(L) and an
amino group (N8,H29; cf. Fig. 1) at the linkage of the two
hapten rings is the most stable. Also observed are hydrogen
bonds to Trp-90(L), Gln-88(L), and Ile-96(L), as well as
(not shown) a weak one to Tyr-31(L) and a fluctuating one
to Asp-49(L).
Fig. 8 quantifies the above statement. Shown is the
strength of the relevant hydrogen bonds and that of the van
der Waals contacts between hapten and the relevant binding
pocket residues “R” (encoded via the thickness of the lines)
during the equilibration period. Although the strength of the
interactions fluctuates, as can be expected from the dynam-
ics of the system, no overall and significant change of the
interaction “fingerprint” is observed. Consider, e.g., the
hydrogen bond to Tyr-33(L), which weakens at 970 ps, but
is completely restored afterward at 1150 ps. With a possible
exception of the bond to Asp-49(L), which appears some-
what weaker than in the x-ray structure, the interaction
network and, thus, the binding pocket region remain intact
after equilibration.
From the above results we conclude that the AN02/
hapten bond is described by our simulations to sufficient
accuracy. Thus the obtained equilibrated structure provides
an appropriate starting point for the subsequent FPMD
simulations, the results of which will be described. We also
consider the period between 550 and 1500 ps suitable to
provide an ensemble from which independent starting struc-
tures for otherwise identical FPMD simulations can be
extracted as a check for reproducibility and to improve the
statistics of the simulation results.
Enforced unbinding of the AN02
antibody/hapten complex
Two sets of FPMD simulations were carried out. To study
the variation of unbinding force on the pulling velocity vcant
and to check to what extent unbinding pathways and force
profiles depend on vcant, 29 simulations with vcant between
0.1 and 50 m/s were carried out. For structural analysis and
computation of force profiles, only the simulations with
vcant  2 m/s were considered, for which friction was found
to be negligible (Heymann and Grubmu¨ller, 1999a). Within
that range, as already described (Heymann and Grubmu¨ller,
1999a), unbinding forces were found to agree well with the
expected logarithmic velocity dependency (Bell, 1978;
Grubmu¨ller et al., 1996; Evans and Ritchie, 1997; Isralewitz
et al., 1997).
To study the nature and extent of structural heterogeneity
of the unbinding pathway, an additional 20 FPMD simula-
tions were carried out and analyzed, each of 300 ps length.
FIGURE 7 Interaction network between bound DNP-hapten (gray) and
AN02 binding pocket after equilibration. Strong hydrogen bonds between
the hapten and binding pocket residues are indicated by dotted lines.
Residues are numbered as in the x-ray structure (Bru¨nger et al., 1991) and
differ by one from the numbering used by Martinez-Yamout and McCo-
nnell (1994).
FIGURE 8 Sum of electrostatic and van der
Waals interactions between DNP-hapten and indi-
vidual residues of the light chain (top half of the
plot) and the heavy chain (bottom half) during equil-
ibration. The thickness of the lines reflects the
strength of the interactions.
1302 Heymann and Grubmu¨ller
Biophysical Journal 81(3) 1295–1313
These otherwise identical simulations differed in their initial
conformations, which were randomly chosen from the last
820 ps of the equilibration phase.
Force profile
Fig. 9 shows a typical force profile, obtained at vcant  1
m/s. Like the one shown, all computed force profiles exhibit
several force barriers in the course of the unbinding process.
For most of them, the force maximum (which determines
the unbinding force) is located at cantilever positions zcant
4 Å; i.e., the force maximum is traversed rather early in the
unbinding process, and correspondingly short unbinding
lengths were obtained. Furthermore, for zcant 4 Å all force
profiles exhibit very similar shapes, whereas for zcant 4 Å,
significant variations appear.
This finding suggests to split the unbinding pathway into
two parts. The similar force profiles of the first 4 Å (sub-
sequently denoted as part A) as obtained from several
FPMD simulations indicate that the geometry and the se-
quence of hydrogen bond ruptures during unbinding should
vary only slightly, which turned out to be the case. The
following subsection characterizes this part of the unbinding
pathway.
In contrast, the subsequent portion of the unbinding path-
way (denoted as part B) exhibits a surprisingly large struc-
tural heterogeneity, which causes the observed variation of
the respective parts of the force profiles (data not shown).
This heterogeneity is one main focus of this paper and is
analyzed in two further subsections.
Initial unbinding steps
Three snapshots at zcant  0 Å, 2 Å, and 4 Å, respectively
(Fig. 10) illustrate the first unbinding steps of the AN02/
DNP-hapten complex. Here the hydrogen bonds and van der
Waals contacts are indicated by dashed lines. The first
significant event in the unbinding process, seen in all FPMD
simulations, is the breakage of the (relatively weak) hydro-
gen bond between the side-chain nitrogen atom of Gln-
88(L) and the nitro group (N26,O27,O28) of the hapten
(small arrow in the first snapshot). Subsequently, and
caused by this rupture, the hapten DNP ring rotates in a
clockwise direction, and the nitro group is slightly reori-
ented toward the exit of the binding pocket. Simultaneously,
a water bridge between Gln-88(L) and the same nitro group
(not shown) disappears.
Subsequently (second and third snapshot), several
changes in the interaction network between the hapten mol-
ecule and the binding pocket residues occur, apparently
independently of each other. Accordingly, the exact se-
FIGURE 9 “Force profile” of enforced AN02/DNP-hapten unbinding.
Shown is the pulling force exerted on the hapten molecule during unbind-
ing as a function of cantilever position zcant. The force maximum at zcant 
4.0 Å is interpreted as the unbinding force.
FIGURE 10 Three snapshots (a–c) of the initial steps (part A) of the
hapten (gray) unbinding pathway. Shown are relevant residues of the
binding pocket and the main interactions observed in the simulations such
as hydrogen bond and van der Waals contacts (dashed lines). The respec-
tive cantilever positions zcant are indicated at the right. The black arrow
indicates the pulling direction.
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quence of these changes varies among the simulations and is
therefore left undefined.
One of these is that van der Waals contacts between the
Ile-96(L) side chain and the nitro group of the hapten DNP
ring weaken, and the hydrogen bond between the nitrogen
atom in the 5-ring of Trp-90(L) and the oxygen atom in the
same hapten nitro group ruptures, as also does the hydrogen
bond between the hydroxyl group of Tyr-33(L) and the
amino group. The latter event induces a conformational
change of the hapten during which the linkage between the
two rings suddenly flips into another configuration, result-
ing in a slight motion of the hapten molecule away from the
light chain and toward the heavy chain. In parallel, the side
chains of Trp-90(L) and Trp-100(H) move away from the
hapten DNP ring, thereby opening the sandwich configura-
tion. Additionally, the Trp-100(H) side-chain moves deeper
into the binding pocket, thereby showing considerable flex-
ibility. The changed orientation of the Trp-100(H) side-
chain causes, in turn, an increased flexibility of the amino-
ethyl-amino chain of the hapten molecule. Several of the
FPMD simulations show transient hydrogen bonds between
this chain and the hydroxyl groups of Tyr-51(H) and Tyr-
54(H).
All these events are accompanied by an initial unbinding
motion of the hapten molecule, whose DNP ring moves out
of the tryptophane sandwich toward the exit of the binding
pocket.
Structural heterogeneity
The subsequent unbinding motions show much larger con-
formational variations. Interestingly, upon closer analysis,
the chronological order of the previous steps described so
far turned out to determine the nature of the subsequent
unbinding motions. In particular, two critical events were
identified that acts as a “switch” and thus completely de-
termine the subsequent steps. These two critical events were
1) rupture of the hydrogen bond to Tyr-33(L), and 2)
opening of the tryptophane sandwich and release of the
hapten DNP ring.
Fig. 11 characterizes the two variants by two series of
snapshots of the unbinding process, which we denote as
“light chain route” (left) and “heavy chain route” (right),
respectively. The snapshots were obtained from two simu-
lations that both started from the same configuration (top).
The simulations were selected because they show the fea-
tures of both pathways particularly clearly. Other simula-
tions, the complete ensemble of which will be analyzed
further below, can be considered as mixtures of these two
prototypic pathways, sharing features of both. These are
typically those for which the two critical events overlap in
time such that their chronological order is not well defined.
Those simulations in which the tryptophane sandwich
opens early before rupture of the hydrogen bond between
Tyr-33(L) and hapten proceed with the “light chain route.”
Here, after the DNP ring is released from the sandwich, the
hapten molecule is free to move toward the light chain (first
snapshot on the left). As a consequence, a number of tran-
sient and relatively strong interactions [mainly van der
Waals contacts and hydrogens bonds (dashed lines) and
water bridges (not shown)] form between the hapten mole-
cule and several residues of the light chain, in particular to
Asp-49(L) and Tyr-31(L) (second snapshot). No strong
interactions to heavy chain residues are seen.
Those simulations in which the hydrogen bond between
Tyr-33(L) and hapten ruptures earlier, i.e., while the tryp-
tophane sandwich is still intact, proceed with the “heavy
chain route” (snapshots on the right). Apparently, and al-
though the hapten DNP ring is still stabilized by the tryp-
tophane sandwich, rupture of this critical hydrogen bond
induces a jump of the hapten amino group toward the heavy
chain. The subsequent strong interactions between the ami-
no-ethyl-amino chain of the hapten molecule and Tyr-51(H)
and Tyr-54(H) (middle), as well as between the nitro group
(N23,O24,O25) of the hapten DNP ring and the hydroxyl
group of Tyr-54(H) (bottom) forces the hapten molecule to
“slide” along the heavy chain side of the binding pocket.
Here, no interactions with light chain residues are observed.
The top two panels of Fig. 12 serve to quantify and
confirm the above qualitative picture of both the “light
chain route” (left panels) and the “heavy chain route” (right
panels). Shown are “interaction fingerprints” which display,
encoded by the thickness of the respective traces, the
strength of interactions between the hapten molecule and
selected binding pocket residues in the course of the simula-
tions and, via zcant tvcant, as a function of cantilever position.
As can be seen, for the “light chain route” the interactions
between the hapten molecule and the light chain residues
persist much longer (until zcant  10 Å) than for the “heavy
chain route” (until zcant  5 Å). This is observed for both the
interactions to individual binding pocket residues and the total
interaction energy between the hapten molecule and the light
chain [(lightchain)] and the heavy chain [(heavychain)].
The opposite correlation, though somewhat weaker, is
observed for the interactions to heavy chain residues. Al-
though, in contrast to the interactions with the light chain
residues, no significant difference in the duration of these
interactions is seen, they become significantly weaker at
zcant  4 Å for the “light chain route” as compared to the
“heavy chain route.” The critical interaction here is the
hydrogen bond between the hapten molecule and Tyr-
54(H), which is formed transiently in the range zcant  4–8
Å for the “heavy chain route,” but which is nearly absent for
the “light chain route.” There, also, the interactions to
Tyr-54(L) vanish at an earlier stage of the unbinding process.
Also, the force profiles reflect which route is taken (bot-
tom panels in Fig. 12). In particular, the unbinding force,
i.e., the maximum of the force profile, correlates with the
unbinding route: significantly larger unbinding forces (400–
450 pN) are observed for the “heavy chain route” than for
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the “light chain route” (250–300 pN). This finding explains
the surprisingly large scatter of unbinding forces (Heymann
and Grubmu¨ller, 1999a), which we found to be larger than,
e.g., in the streptavidin/biotin system studied earlier (Grub-
mu¨ller et al., 1996). Given the accuracy of single-molecule
AFM experiments, we expect the scatter to also show up in
such experiments, for example as a deviation from the usual
Gaussian distribution of measured unbinding forces. In con-
trast, the unbinding length appears to be unaffected, as should
also therefore be the case for the logarithmic slope of unbind-
ing forces when measured as a function of loading rate.
We now consider the whole ensemble of the 20 FPMD
simulations carried out at vcant  5 m/s as described in the
Methods section. As stated above and easily discernible in
Fig. 13, the 20 unbinding trajectories cover a whole spec-
trum of unbinding pathways in which the “light chain route”
FIGURE 11 Snapshots taken from FPMD simulations with varying unbinding pathways. The left snapshots illustrate the “light chain route,” the right
ones the “heavy chain route.” The cantilever positions of the snapshots are zcant  0 Å (top), zcant  5 Å (middle), zcant  10 Å (bottom), respectively.
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and the “heavy chain route” appear as extreme cases. Shown
are (in a different color for each of the 20 FPMD simula-
tions) the traces of the hapten center of mass as it moves out
of the binding pocket during unbinding. The initial (equil-
ibrated) structure is shown in gray (hapten) and orange
(binding pocket residues). Also shown are the unbound
states for the “light chain route” as well as for the “heavy
chain route,” with the final structures of the hapten shown in
yellow and green, respectively.
As can be seen, for the initial phase of the simulations
(part A), the traces stay within a relatively narrow region;
after the force maximum at zcant  4 Å (start of part B,
indicated by a red dashed line), the traces spread out like a
fan. This transition point is defined by the release of the
hapten DNP ring from the tryptophan sandwich and coin-
cides with the force maximum. Such structural heterogene-
ity is a well-known feature of ensembles of protein struc-
tures, which was first observed by Frauenfelder and others
(Ansari et al., 1985; Frauenfelder et al., 1989) and was later
seen also in MD simulations (Elber and Karplus, 1987;
Schulze et al., 2000). For the AN02/DNP system, our
FPMD simulations predict a similar structural heterogeneity
for (nonequilibrium) reaction pathways. Such structural
heterogeneity should give rise to a significant entropic con-
tribution to the free energy barrier that separates the bound
from the unbound state. The following subsection attempts
to estimate the size of that entropic contribution.
Entropic contribution to the AN02/DNP-hapten bond
As a measure for the entropic contribution to the free energy
landscape along the unbinding pathway, we used the volume in
configurational space that is occupied by the pathway bundle
obtained from the 20 FPMD simulations. The relative volume
change as a function of zcant (with respect to the bound state)
has been estimated by PCA analysis (Eqs. 10 and 11).
Fig. 14 shows entropy estimates for T  300 K, taking
into account the m  50, 55, 60, . . . , 100 most significant
degrees of freedom, as defined by the eigenvalues of the
covariance matrix. As can be seen, the curves converge well
above m  70, thereby also providing an estimate of the
number of degrees of freedom that change their dynamics in
the course of unbinding. The fact that the entropy estimate
converges at a smaller number (70) of dimensions than the
number of coordinate sets used for each value of zcant (400)
also justifies the choice of the size of the intervals Ii as
defined in Fig. 3.
The obtained entropy landscape shows a rapid increase
for part B of the unbinding pathway (zcant  4 Å), in
agreement with the observation of a pronounced divergence
of unbinding pathways after release of the hapten DNP ring
from the tryptophan sandwich at that point. Given the total
unbinding free energy of 15 kcal/mol, this entropy jump of
6 kcal/mol is indeed a significant contribution.
A few caveats are, however, mandatory. First, nonequi-
librium reaction pathways have been used. This generally
underestimates the equilibrium values because the region of
phase space that is sampled with the relatively short simu-
lation time may be smaller than the region covered by an
equilibrium Boltzmann ensemble. Second, our approach
implies that all degrees of freedom perpendicular to the
reaction pathway are in equilibrium at all times. This as-
sumption is often made, e.g., in Kramers’ transition state
FIGURE 12 Interaction “fingerprints” (top) and force profiles (bottom) obtained from two representative simulations that took the “light chain route”
(left) and the “heavy chain route” (right), respectively. The “fingerprints” show the strength of individual interactions between the hapten molecule and the
relevant binding pocket residues “R” and the total interaction energies between the hapten molecule and the light chain [(lightchain)] and the heavy chain
[(lightchain)], respectively, as a function of cantilever position zcant. The thickness of the lines denotes the interaction energy.
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theory (Eyring, 1935; Kramers, 1940) or within the molec-
ular dynamics field, for the calculation of free energies by
“umbrella sampling” or related methods. The fact that the
observed pathways overlap and that jumps between path-
ways are seen suggests that for AN02/DNP unbinding this
assumption is not severely violated.
The third caveat concerns a more technical issue. Al-
though generation of an ensemble of 20 trajectories is
clearly an improvement with respect to the many studies
that are based on one or two simulations, it is still a very
small ensemble for the purpose of an entropy estimate.
By trading off spatial resolution, we have increased that
ensemble to 400 such that up to hundred collective de-
grees of freedom could be reasonably considered. Indeed,
within this limited range, convergence is seen. However,
by including adjacent coordinate sets taken from the
same trajectory into our estimate, we have introduced
correlations. Therefore, the effective ensemble size may
be 400, in which case the seen convergence might be
artificial. We assume the effect of limited ensemble size
to be more severe for phase B of the unbinding pathway,
where a larger region of configuration space has been
sampled, resulting in an underestimate of the correspond-
ing entropic contribution as well.
Finally, to avoid that the hapten encounters the bound-
ary region of the simulation system, we have slightly
restricted the motion of the hapten by subjecting atom O2
to a weak harmonic potential perpendicular to the pulling
direction. Accordingly, two of the three degrees of free-
FIGURE 13 Unbinding pathways for 20
FPMD simulations, each with pulling velocity
5 m/s, but slightly differing initial conditions.
Shown are the traces (colored lines) of the
hapten center of mass and the starting struc-
ture (hapten: gray; binding pocket residues:
orange). For the two extreme routes, the un-
bound hapten molecule as seen at the end of
the simulation at zcant  15.0 Å is shown in
yellow and green. The red dashed line indi-
cates the force maximum that separates the
unbinding pathway into the two parts A and B
referred to in the text.
FIGURE 14 Entropic contribution TSm(zcant) (at T  300 K) to the free
energy landscape along the unbinding reaction pathway as a function of
cantilever position zcant. The individual traces have been obtained by taking
the m  50, 55, 60, . . . , 100 most significant degrees of freedom into
account.
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dom describing the center of mass motion of the hapten
will be slightly restricted and, hence, their contribution to
the entropy may be somewhat underestimated. Because,
however, nearly 100 (collective) degrees of freedom con-
tribute significantly to the entropy, we consider this
artifact negligible.
In summary, we assume that our entropy estimate can
serve as a lower limit for the true entropic contribution to
the unbinding free energy landscape.
Enforced unbinding for two AN02 mutants
As already discussed, certain residues of the AN02 binding
pocket strongly interact with the hapten molecule (see, e.g.,
Fig. 12). Particularly strong bonds are formed to the light
chain residues, and mutations of those affect the AN02/
DNP-hapten binding free energy (Martinez-Yamout and
McConnell, 1994). In this section we ask whether such
mutations can also alter the unbinding force. To that end,
the two critical residues shown in Fig. 15, Tyr-33(L) (green)
and Ile-96(L) (red), were chosen as mutation sites, and the
respective mutant structures of the AN02 antibody were
modeled and subjected to FPMD simulations.
In the first mutant, Y33F(L), the strong hydrogen bond
between the hydroxyl group of Tyr-33(L) and the amino
group (N8,H29) of DNP-hapten was deleted by replacing
the tyrosine with a phenylalanine. Accordingly, decreased
unbinding forces for that mutant were expected. With the
second mutant, I96K(L), we aimed at an increased unbind-
ing force as compared to the wild-type complex. To this
end, Ile-96(L) was replaced by a lysine that was expected to
form an additional hydrogen bond to the oxygen atom O25
of the DNP ring.
Modeling of these two mutants was performed as de-
scribed in the Methods section. No severe structural distor-
tions were expected because the two mutations did not
induce sterical strain into the structure of the binding
pocket. This was checked by monitoring the rms deviation
of the binding pocket from the wild-type x-ray structure
during equilibration as well as the interactions between
hapten and the remaining binding pocket residues (data not
shown). Indeed, none of these observables differs signifi-
cantly from those monitored during equilibration of the wild
type. We therefore assume that our models of the two
mutants are accurate.
Starting from the respective equilibrated structures, 22
FPMD simulations per mutant were carried out using pull-
ing velocities between 2 and 50 m/s. Fig. 16 compares the
obtained unbinding forces with those obtained for the wild
type. Unbinding forces for the wild-type complex (●), the
Y33F(L) mutant (), and the I96K(L) mutant ({), respec-
tively, are plotted as a function of pulling velocity vcant.
Surprisingly, no significant difference for the calculated
unbinding forces is seen. After rescaling the computed
unbinding forces to typical experimental time scales (Hey-
mann and Grubmu¨ller, 1999a), we obtain 68  25 pN for
the Y33F(L) mutant and 73  20 pN for the I96K(L)
mutant, which is to be compared with the unbinding force of
65  25 pN for the wild-type complex (Heymann and
Grubmu¨ller, 1999a). For rescaling, a dissociation constant
of k  110 s1 was used for all three cases because that
quantity only weakly affects the results.
For an explanation for this result, first consider the snap-
shots in Fig. 17, which show the binding pocket of the
Y33F(L) mutant and the bound hapten (gray) after equili-
bration (top) and at zcant  4 Å (bottom); the removed
hydrogen bond is tagged with a cross. That hydrogen bond,
however, is subsequently fully restored by Tyr-31(L) which,
as can be seen in the bottom snapshot, is close to Phe-33(L)
FIGURE 15 Location of the two site-directed light chain mutants of the
AN02/DNP-hapten complex, Y33F(L) (green) and I96K(L) (red), de-
scribed in the text.
FIGURE 16 Unbinding forces of the AN02/DNP-hapten complex as a
function of pulling velocity for the wild type (●), the Y33F(L) mutant (),
and the I96K(L) mutant ({).
1308 Heymann and Grubmu¨ller
Biophysical Journal 81(3) 1295–1313
and moves toward the hapten amino group during unbind-
ing, thereby perfectly replacing the wild-type Tyr-33(L).
The energetics of this process is obtained from the inter-
action fingerprint shown in Fig. 18 (top). As intended, the
Phe-33(L) bond to the hapten is weakened to a large extent
with respect to the Tyr-33(L) interactions in the wild type
(cf. also Fig. 12). As described above, subsequently pro-
nounced interactions between Tyr-31(L) and hapten build
up for zcant  4 Å and reach their maximum in the range
between 6 and 8 Å. Additionally, and possibly triggered by
the motion of Tyr-31(L), a strong bond is formed to Asp-
49(L). In line with this finding, mutations of Asp-49(L),
e.g., D50T(L) and D50S(L), also show changed binding
constants (Martinez-Yamout and McConnell, 1994).
Both bonds contribute to the total interaction energy,
which in this region is even larger than it is after equilibra-
tion. As a result, the corresponding force profile (Fig. 18,
bottom) exhibits a second barrier in this part of the unbind-
ing process. In many of the simulations, this barrier was
similar in size to the first barrier; in several of the FPMD
simulations the second barrier even dominated the first
barrier and thus determined the unbinding force. To enable
such a tyrosine swap, the binding pocket region must obvi-
ously be highly flexible.
For the I96K(L) mutant, the fingerprint for a typical
FPMD probe simulation (Fig. 19, top) confirms the intended
new strong interaction between the Lys-96(L) and hapten.
Apparently, this interaction is indeed very stable, as it is
FIGURE 17 Snapshots of the binding pocket during enforced unbinding
for the Y33F(L) mutant. Top: bound state after equilibration; the removed
hydrogen bond is indicated. Bottom: intermediate at zcant  4 Å. A newly
formed hydrogen bond between hapten and Tyr-31(L) is shown by the
dashed line.
FIGURE 18 Interaction fingerprints (top) and force profile (bottom) for
an FPMD simulation of the Y33F(L) mutant with vcant  1 m/s.
FIGURE 19 Interaction fingerprint (top) and force profile (bottom) of
the I96K(L) mutant for an FPMD simulation with vcant  1 m/s.
Antibody/Antigen Unbinding Simulations 1309
Biophysical Journal 81(3) 1295–1313
almost unchanged for a long period during enforced unbind-
ing, until zcant  8 Å. The force profile (bottom), however,
does not exhibit higher maxima than the wild-type force
profiles. Instead, the maximum broadens and the average
force in this part of the pathway is larger without affecting
the unbinding force.
The strong and long-lasting interaction to Lys-96(L) is
explained in Fig. 20. After equilibration (top), the side chain
of Lys-96(L) interacts with the oxygen atom O25 of the
DNP ring (dashed line), which was the rationale for con-
sidering that mutant. Compared to the wild-type isoleucine,
however, the lysine side chain turned out to be significantly
more flexible. It was therefore dragged by the hapten mol-
ecule during the first unbinding steps and moved toward the
binding pocket exit. As a consequence, the interactions
between hapten and Lys-96(L) stayed essentially intact for
an extended period, as already was evident from the inter-
action fingerprint. Furthermore, after rupture of that hydro-
gen bond (bottom of Fig. 20), a water molecule (also shown
in the bottom snapshot) moved in between the hapten and
Lys-96(L) and formed a transient water bridge. At this
instance, although the hapten DNP ring had already been
released from the tryptophan sandwich, the equilibrium
interaction network was still partly in place. It is this slower
breakdown of this interaction network, as compared to the
wild type, that causes the barrier in the force profile to
become broader rather than higher, again leaving the un-
binding force essentially unchanged.
Viewed from a more general angle, the fact that no
change of unbinding forces is seen in the above two muta-
tion studies—whereas binding free energies do change—is
probably less surprising, as it may appear at first sight. Note
that, because free energies are thermodynamic state vari-
ables, free energy differences always add up to zero in a
thermodynamic cycle. Therefore, to estimate the effect of a
mutant on the binding free energy, it suffices to consider its
effect on the bound state, i.e., how much the interaction free
energy with the ligand is altered, e.g., due to removal of a
single hydrogen bond. Accordingly, the binding free energy
is independent of the unbinding pathway. Vice versa, no
information on the unbinding pathway can be extracted
from binding free energies.
As illustrated in Fig. 21, the situation is more complex for
unbinding forces. Here, mutations or other changes may or
may not affect the unbinding force, depending on how large
their effect is and depending on which part of the reaction
pathway is affected. Panel A illustrates one of the many
possibilities for which a mutation will not affect the unbind-
ing force. That force is generally determined by the maxi-
mum in the force profile (solid line), here at position①. The
change induced at position ② (dashed line), unless large,
FIGURE 20 Snapshots of the binding pocket during enforced unbinding
of the I96K(L) mutant complex. Top: bound state after equilibration.
Bottom: Intermediate at zcant  8 Å. Also shown is a water molecule that
forms a water bridge between Lys-96(L) and the hapten molecule.
FIGURE 21 Modification of individual interactions may or may not
affect the unbinding force, depending on the part of the reaction pathway
at which they take place. See text for discussion.
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will not affect the unbinding force. In contrast, the binding
free energy, obtained from the integral over the force pro-
file, will obviously be raised.
Only two possibilities remain for which the unbinding
force is actually affected. First (B), a mutation that causes an
additional force component (dashed lines) right within part
① of the pathway that contains the force maximum, will
affect the unbinding force in a way similar to its effect on
the binding free energy. Second (C), an additional force
component that, although at a different position ② is large
enough to exceed the force maximum, will also show up.
Neither of these two cases is realized for the two mutants
described above, and therefore no effect is seen.
In the above sense, binding forces are affected by changes
of the binding pocket in a nonadditive way, and prediction
of the effect requires analysis not only of the bound state,
but also of the whole unbinding pathway. Vice versa, force
probe mutation studies can therefore provide additional
information on the reaction pathway.
We note that cases (B) and (C) can be distinguished
experimentally by dynamic force spectroscopy where the
pulling velocity is varied. Thereby, the position of the force
maximum can be determined (Evans and Ritchie, 1997;
Merkel et al., 1999), and additional information about the
shape of the force profile can be obtained (Heymann and
Grubmu¨ller, 2000).
CONCLUSIONS
Extended force probe molecular dynamics (FPMD) simula-
tions of a solvated AN02/DNP-hapten complex have been
carried out, and the unbinding pathways of the hapten
molecule out of the AN02 binding pocket were analyzed.
Two phases, A and B of the unbinding process, were seen.
During phase A, the hapten molecule is released from the
rigid tryptophan sandwich. Structural and energetic details
of this part of the unbinding pathway are well-defined and
were reproduced in all simulations. In contrast, phase B,
which begins approximately at the force maximum and well
after release of the hapten from the tryptophan sandwich, is
characterized by significant structural heterogeneity of the
unbinding pathways. As two extreme cases, a “light chain
route” and a “heavy chain route” have been described.
Which of the two routes is taken in phase B is already
remarkably predetermined to a high degree in phase A.
Here, the hydrogen bond to Tyr-33(L) acts as a switch and
the timing of breakage of that particular hydrogen bond with
respect to the release from the tryptophan sandwich turned
out to be critical. These findings provide a microscopic
model for the structural heterogeneity found in NMR stud-
ies (Martinez-Yamout and McConnell, 1994).
The large number of FPMD simulations carried out en-
abled us to estimate the entropic contribution to the binding
free energy that results from the observed heterogeneity of
the unbinding pathways. Our approach to compute entropy
curves along reaction pathways from ensembles of trajec-
tories is a straightforward generalization of the established
methods to estimate free energy values or differences from
ensembles of structures. The underlying change of view—
from thermodynamic states to reaction pathways—was in
fact motivated by the corresponding new perspective—from
energies to forces—provided by force probe experiments.
We note that our entropy estimate refers to enforced
unbinding pathways, as observed in AFM experiments and
in our force probe simulations, rather than to spontaneous
unbinding pathways. However, because the configurational
space accessible to the hapten during free unbinding is equal
to or larger than that for directed unbinding, the entropic
contribution to the free energy along the spontaneous un-
binding pathway is presumably even larger than (or at least
not smaller than) the estimate provided here.
The obtained entropic contribution to the binding free
energy barrier of 6 kcal/mol, which we thus consider a
lower limit, is substantial and contributes 40% to the
binding free energy of 15 kcal/mol. Thus it seems safe to
say that for the AN02/DNP-hapten complex, the activation
free energy barrier is significantly lower than the enthalpic
barrier. Accordingly, the binding kinetics is modified by an
entropic contribution that involves a large number of de-
grees of freedom both of the DNP ligand and that of the
antibody. In particular, as can be seen from inspection of the
PCA eigenvectors (data not shown), these degrees of free-
dom are not localized at the binding pocket, and they also
involve residues up to 15 Å apart. This result provides an
explanation for the recent finding that mutations of residues
at that distance from the binding pocket can indeed affect
the AN02 binding kinetics (Wedemayer et al., 1997). Our
results also suggest that, more generally, induced fit mo-
tions like those seen, e.g., for Tyr-31(L) can, through en-
tropic effects, significantly change the binding kinetics.
Within this context one may speculate about the physio-
logical role of the entropic modification of barrier heights
and binding kinetics. We think that such “entropic control”
provides a means to compensate for the enthalpic contribu-
tion to binding free energy barriers. This enthalpic contri-
bution can certainly not be fully adjusted only by variation
of the binding pocket due to the huge diversity of antigens
that have to be bound. However, there is obviously an
optimal value for the binding kinetics: if, for example, the
off-rate were too low, only a few antigens can be bound; if
it were too fast, binding events might not be recognized.
Here, entropic control could, via adjustment of the flexibil-
ity of the binding pocket, tailor the binding energy profile
appropriately.
For the initial steps of antigen binding, the “fan” of
binding pathways most likely provides a means to enhance
the efficiency of antigen binding: because here many con-
figurations ultimately lead down the “binding funnel” to-
ward the fully bound state, proper pre-orientation of the
antigen is presumably not required, and the rate of success-
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ful first encounters is thereby enhanced. The obvious sim-
ilarity to the concept of a protein “folding funnel” (Wolynes
et al., 1995), which has been pointed out previously (Rejto
and Verkhivker, 1996; Kumar et al., 2000), suggests that the
antibody/antigen system, being computationally more easily
accessible than protein folding, may serve as a model sys-
tem for future studies of the “funnel” concept.
Our FPMD simulations of the mutated complexes re-
vealed two interesting mechanisms. First, as seen for the
Y33F(L) mutant, the function of a modified residue can be
adopted by another residue such that the binding force is
essentially unchanged. Second, our results suggest that
binding forces are generally nonadditive with respect to the
underlying individual interatomic interactions like hydrogen
bonds or van der Waals contacts. In particular, adding a new
interaction through site-directed mutations does not neces-
sarily increase the binding force even if the binding free
energy is raised.
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